Peripheral Vasopressor Use in Early Sepsis-Induced Hypotension
Periphere Vasopressor-Anwendung bei früher sepsisbedingter Hypotonie
JAMA Network Open · 27.08.2025 · 8 (8) · e2529148
DOI: 10.1001/jamanetworkopen.2025.29148 ↗Auf einen Blick
In einer prospektiven Kohorten-Analyse aus CLOVERS wurden Vasopressoren meist peripher begonnen. Periphere Gabe war mit seltenen Komplikationen und vergleichbarer 90-Tage-Sterblichkeit verbunden.
Fragestellung
Welche Faktoren sind mit der Wahl des Vasopressor-Zugangs verknüpft, und wie sicher ist die periphere Gabe in der frühen Sepsis-Reanimation?
Methode
Prospektive Kohortenstudie; sekundäre Analyse der CLOVERS-Studie in 60 US-Krankenhäusern von März 2018 bis Februar 2022.
Ergebnisse
Von 582 eingeschlossenen Patient:innen erhielten 490 (84,2 %) Vasopressoren peripher und 92 zentral. 90-Tage-Sterblichkeit: 26,1 % vs. 37,0 %; adjustierte OR 0,67 (95 %-KI 0,39–1,16).
Schlussfolgerung der Autor:innen
Die Autor:innen schlussfolgern, dass die periphere Gabe von Vasopressoren häufig war und mit niedrigen Komplikationsraten verbunden war; die Befunde stützen die Sicherheit und Machbarkeit der kurzfristigen peripheren Anwendung.
Kernaussagen
- Periphere Initiierung bei 490 von 582 Patient:innen
- 90-Tage-Sterblichkeit statistisch vergleichbar
- Periphere Komplikationen selten: 3 von 490 (0,6 %)
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Network Open, online erschienen am 27.08.2025. Verfasst von Elizabeth S Munroe und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor. Hauptthemen laut MEDLINE: Vasoconstrictor Agents, Sepsis, Hypotension, Catheterization, Peripheral. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS.
Themen: Sepsis
Abstract (Originalsprache)
Importance Evidence supporting the safety of infusing vasopressors through peripheral intravenous catheters (peripheral vasopressors) is largely derived from single-center studies, limiting generalizability.
Objective
To evaluate factors associated with vasopressor route selection and assess safety and clinical outcomes of peripheral vasopressor administration in early sepsis resuscitation. Design, Setting, and Participants This prospective cohort study is a secondary analysis of the Crystalloid Liberal vs Early Vasopressors in Sepsis (CLOVERS) trial conducted in 60 US hospitals from March 2018 to February 2022. Patients in CLOVERS who received vasopressors within 24 hours of enrollment and did not have central venous access at enrollment were included. Data were analyzed from January 2023 to June 2025. Exposure Route of vasopressor initiation (central or peripheral). Main Outcomes and Measures The primary analysis evaluated the route of vasopressor initiation, while the secondary analysis assessed continuation of peripheral vasopressors beyond 6 hours. Univariable and multivariable analyses of factors associated with vasopressor route were conducted, as was a multivariable analysis to evaluate the association of route with outcomes, including 90-day mortality. Descriptive statistics were used to summarize 28-day peripheral vasopressor and central venous catheter (CVC) complications.
Results
Of 1563 patients in CLOVERS, 582 (37.2%) received vasopressors and met study inclusion criteria. Included patients had a median (IQR) age of 63 (52-72) years, and 267 (45.9%) were female, 96 (16.5%) were African American, 416 (71.5%) were White, and 70 (12.0%) were another race or had unreported race. Vasopressors were initiated via peripheral catheter in 490 patients (84.2%) and via central venous access in 92 patients (15.8%). Study site was the only factor independently associated with route of initiation (median odds ratio, 3.48; 95% CI, 1.57-5.38). In adjusted analyses, peripheral vs central initiation was associated with statistically comparable 90-day mortality (128 participants [26.1%] vs 34 participants [37.0%]; adjusted odds ratio, 0.67; 95% CI, 0.39-1.16). Peripheral vasopressors were continued beyond 6 hours in 333 of 490 patients (68.0%). Peripheral vasopressor complications were rare and low-grade (3 of 490 patients [0.6%]), with no cases of ulceration or tissue injury. In contrast, there were 14 complications from CVC placement occurring in 12 of 322 patients (3.7%) who had CVCs placed in the first 72 hours. Conclusions and Relevance In this prospective cohort study of the CLOVERS trial, peripheral administration of vasopressors was common and was associated with low complication rates. These findings support the safety and feasibility of short-term peripheral vasopressor use in early sepsis resuscitation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Michigan, Ann Arbor.
- Department of Emergency Medicine, University of Michigan, Ann Arbor.
- Division of Pulmonary Sciences & Critical Care, Denver Health Medical Center, Denver, Colorado.
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Oregon Health and Science University, Portland.
- Department of Surgery, University of Michigan, Ann Arbor.
- Division of Pulmonary and Critical Care Medicine, Intermountain Health, Murray, Utah.
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Munroe, E. S., Co, I. N., Douglas, I., Hyzy, R., Khan, A., Nelson, K., Park, P. K., Peltan, I. D., Rice, T. W., Seelye, S., Self, W. H., Shapiro, N. I., Prescott, H. C., & NHLBI PETAL Network (2025). Peripheral Vasopressor Use in Early Sepsis-Induced Hypotension. JAMA Network Open, 8(8), e2529148. https://doi.org/10.1001/jamanetworkopen.2025.29148
Vancouver
Munroe ES, Co IN, Douglas I, Hyzy R, Khan A, Nelson K, et al. Peripheral Vasopressor Use in Early Sepsis-Induced Hypotension. JAMA Network Open. 2025;8(8):e2529148. doi:10.1001/jamanetworkopen.2025.29148
BibTeX
@article{Munroe2025,
author = {Munroe, Elizabeth S and Co, Ivan N and Douglas, Ivor and Hyzy, Robert and Khan, Akram and Nelson, Kristine and Park, Pauline K and Peltan, Ithan D and Rice, Todd W and Seelye, Sarah and Self, Wesley H and Shapiro, Nathan I and Prescott, Hallie C and NHLBI PETAL Network, NHLBI PETAL Network},
title = {Peripheral Vasopressor Use in Early Sepsis-Induced Hypotension},
journal = {JAMA Network Open},
year = {2025},
volume = {8},
number = {8},
pages = {e2529148},
doi = {10.1001/jamanetworkopen.2025.29148}
}
EUVIMED